Companies Cryptocurrencies
Kamada Ltd
Kamada Ltd
Exchange: Nasdaq Global Select
IPO Date: 01/08/2005
CEO: Mr. Amir London
Biotechnology Healthcare 🔗
  • KMDA
  • 5.645
  • 252587776
    market cap
  • -0.00500011
If you bought

shares of Kamada Ltd (KMDA) on
You would have made
Old Price $12 Current Price $12

Kamada Ltd. engages in the development and production of pharmaceutical products. The company offers bio-therapeutics for human use, such as specialty proteins, specific immunoglobulins, and other prescription medicines. The Company’s product line includes intravenous AAT for chronic replacement therapy in individuals with congenital alpha-1 antitrypsin deficiency; KamRAB for prophylaxis of rabies infection; KamRho-D IM for prophylaxis of Rh hemolytic disease of the newborn; KamRho-D IV for treatment of immune thrombocytopenic purpura; and IVIG, a replacement therapy in primary and secondary immune therapy. Its product line also comprises Protosol to reduce blood loss in patients undergoing cardiac surgery; Heparin sodium injection for coagulation inhibition and prophylaxis of thromboembolic diseases and Heparin Lock Flush to maintain potency of intravenous injection device among other.

Address: 2 Holtzman St. Science Park Rehovot

Stay updated.